These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 24743131)
1. [Bacterial phagelysates and malignant tumor growth]. Gambashidze K; Bejitashvili N; Azaladze T; Pkhaladze M; Azaladze A Georgian Med News; 2014 Mar; (228):92-5. PubMed ID: 24743131 [TBL] [Abstract][Full Text] [Related]
2. Antitumor and adjuvant effects of phagelysates of E.coli in mice with Ehrlich carcinoma. Gambashidze K; Khorava P; Azaladze T; Kalandarishvili K; Jaiani E; Lasareishvil B; Azaladze A; Tediashvili M Exp Oncol; 2012 Jul; 34(2):107-11. PubMed ID: 23013762 [TBL] [Abstract][Full Text] [Related]
3. [Application of bacterial thermo-and phagelysates for suppression of malignant tumor growth in experimental studies: 1. Anticancer efficacy of thermo- and phagelysates of E.coli]. Gambashidze KG; Khorava PA; Kalandarishvili KG; Lasareishvili BG; Dzhaiani EG; Azaladze AT; Tediashvili MI Georgian Med News; 2012 Jan; (202):42-7. PubMed ID: 22392782 [TBL] [Abstract][Full Text] [Related]
4. [Application of bacterial thermo- and phagelysates for suppression of malignant tumor growth in experimental studies: 2 comparative analysis of anticancer efficacy of thermo- and phagelysates of Ps. aeruginosa and E. coli]. Gambashidze KG; Kalandarishvili KG; Khorava PA; Azaladze TN; Lasareishvili BG; Dzhaiani EG; Tediashvili MI Georgian Med News; 2012 Jun; (207):50-6. PubMed ID: 22859451 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of marine bacteria, Vibrio anguillarum, in mice. Shimizu T; Nitta M; Mifuchi I Gan; 1979 Aug; 70(4):429-33. PubMed ID: 510844 [TBL] [Abstract][Full Text] [Related]
6. [Study of indirect active immunotherapy of Ehrlich carcinoma]. De Santana CF; Da Silva IN Rev Inst Antibiot (Recife); 1974 Dec; 14(1-2):3-8. PubMed ID: 4471334 [TBL] [Abstract][Full Text] [Related]
7. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody. Saha S; Mondal S J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834 [TBL] [Abstract][Full Text] [Related]
8. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors. Abe S; Yoshioka O; Masuko Y; Tsubouchi J; Kohno M; Nakajima H; Yamazaki M; Mizono D Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591 [TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of combined use of OK-432 and yeast cell wall with mitomycin-C in mice. Mashiba H; Gojobori M; Matsunaga K Gan; 1977 Oct; 68(5):703-8. PubMed ID: 590687 [TBL] [Abstract][Full Text] [Related]
10. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. del Carmen MG; Rizvi I; Chang Y; Moor AC; Oliva E; Sherwood M; Pogue B; Hasan T J Natl Cancer Inst; 2005 Oct; 97(20):1516-24. PubMed ID: 16234565 [TBL] [Abstract][Full Text] [Related]
11. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM. Saha S; Mondal S Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041 [TBL] [Abstract][Full Text] [Related]
12. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice. Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197 [No Abstract] [Full Text] [Related]
13. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment. Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells. Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of subcutaneous growth of Ehrlich ascites carcinoma (EAC) tumor by post-immunization with EAC-cell gangliosides and its anti-idiotype antibody in relation to tumor angiogenesis, apoptosis, cell cycle and infiltration of CD4+, CD8+ lymphocytes, NK cells, suppressor cells and APC-cells in tumor. Mondal B; Saha S Indian J Exp Biol; 2011 Aug; 49(8):574-84. PubMed ID: 21870425 [TBL] [Abstract][Full Text] [Related]
16. [Immunogenicity of cancer-associated and cancer-specific antigens]. del Pozo AM; Valladares Y; Alvarez-Rodríguez Y; Alvarez-Noves J Rev Esp Oncol; 1982; 29(4):685-700. PubMed ID: 6927369 [TBL] [Abstract][Full Text] [Related]
17. Combined treatment with anaerobic Corynebacterium liquefaciens and chemotherapeutics against solid tumor in mice. Hattori T; Yamagata S Gan; 1977 Feb; 68(1):115-20. PubMed ID: 863171 [TBL] [Abstract][Full Text] [Related]
18. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma]. Donenko FV; Kabieva AO; Moroz LV Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491 [TBL] [Abstract][Full Text] [Related]
19. [The effect of antitumor vaccine on the recurrence of solid tumors in mice subjected to surgery]. Zatula DG; Bikhunov VL; Zagoruĭko EE Eksp Onkol; 1984; 6(1):47-9. PubMed ID: 6499731 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors. Ciria HC; Quevedo MS; Cabrales LB; Bruzón RP; Salas MF; Pena OG; González TR; López DS; Flores JM BMC Cancer; 2004 Nov; 4():87. PubMed ID: 15566572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]